Browse Lung Cancer Articles by Topic

Sunvozertinib (Zegfrovy) Tablets

The U.S. Food and Drug Administration (FDA) has granted an accelerated approval to sunvozertinib, a third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) for the treatment of non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 20 insertion mutations (EGFR exon20ins). The FDA also approved a companion diagnostic device, Oncomine Dx Express Test to help detect exon20ins mutations.

Taletrectinib Capsules (Ibtrozi)

The U.S. Food and Drug Administration has approved a potent, selective, next-generation ROS Proto-Oncogene 1 (ROS1) receptor tyrosine kinase inhibitor, taletrectinib, for the treatment of ROS1-positive non-small cell lung cancer.

Telisotuzumab Vedotin-tlly (Emrelis)

The U.S. Food and Drug Administration has granted accelerated approval of telisotuzumab vedotin-tilly, a first-in-class c-mesenchymal-epithelial transition factor-directed antibody and a microtubule inhibitor conjugate for the treatment of locally advanced or metastatic, non-squamous non-small cell lung cancer.

Patient Pool Eligible for Lung Cancer Screening Expands Under Amended Criteria

CMS lowers age, smoking history thresholds.

Report: Record Year-Over-Year Decline in Cancer Death Rate

Fewer smokers, better detection and treatment methods credited with saving lives.

Delayed Screenings Correlate with More Severe Lung Cancer Malignancies

COVID-19 led to canceled or delayed care in 2020 — with consequences.

Mixed News for Lung Health

Deaths from lung cancer are on the decline, while deaths from lung clots are on the rise, according to a pair of new reports.

Selpercatinib Capsules (Retevmo)

Selpercatinib should be prescribed to treat metastatic rearranged during transfection (RET) fusion-positive, non-small cell lung cancer and advanced or metastatic RET-mutant medullary thyroid cancer.

B Vitamins and Lung Cancer Risk

These researchers investigated the use of supplemental vitamin B6, folate, and B12 and the risk of lung cancer in 77,118 participants in the Vitamins and Lifestyle cohort, finding an increased risk of lung cancer in men, which was exacerbated by smoking.

Occurrence of Second Malignancies after Treatment for Hodgkin's Lymphoma: Who's at Fault?

Capitalizing on a large cohort of British patients followed after treatment for Hodgkin's lymphoma, the risk of occurrence of second malignancy was assessed in the context of treatment with chemotherapy alone vs treatment with combined chemotherapy and radiation.